Michelle Lofwall, MD, board-certified in psychiatry and addiction medicine, is a Professor Departments of Behavioral Science and Psychiatry and the Bell Alcohol and Addictions Endowed Chair at the University of Kentucky (UK). She is the medical director of UK’s Robert Straus and First Bridge Clinics, which provide comprehensive opioid addiction treatment within the UK Center on Drug and Alcohol Research. Her passion is in improving the care of patients with substance use disorders. Her research has included evaluation of novel treatments for opioid use disorder (e.g., buprenorphine implants and depot injections), physician training, understanding factors associated with buprenorphine diversion, improving care of complex patients with OUD and deep-seated infections, and creating novel programs involving peers support specialists and care navigators to aid in substance use disorder treatment engagement and retention. She is a Distinguished Fellow of American Society of Addiction Medicine (ASAM) and the American Psychiatric Association and has served as expert panel member for the Substance Abuse and Mental Health Service Administration Treatment Improvement Protocol on Medication Treatment for Opioid Use Disorder (TIP 63) and invited speaker to the National Academy of Medicine. She enjoys educating health care providers, community leaders and policy makers about the importance of access to evidence-based treatments and providing parity for this chronic illness as we do for other medical illnesses.
Larissa Mooney, MD is a Professor and Director of the Addiction Sciences Division in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC), a role she assumed in 2026. Her work focuses on education, clinical services, and research related to substance use disorders, with emphasis on co-occurring substance use and mental health conditions.
Prior to joining MUSC, Dr. Mooney served as Professor and Director of the Addiction Psychiatry Division at the University of California, Los Angeles (UCLA). She directed the UCLA Addiction Psychiatry Clinic and the UCLA–VA Addiction Psychiatry Fellowship Program and served as Deputy Chief of the Substance Use Disorders Subdivision at the Greater Los Angeles VA Healthcare System. During her tenure at UCLA, she conducted clinical research within the UCLA Integrated Substance Use and Addiction Programs and served as one of two Principal Investigators for the Greater Southern California Node of the National Institute on Drug Abuse Clinical Trials Network. Dr. Mooney completed her psychiatry residency at New York University and a fellowship in addiction psychiatry at Cedars-Sinai Medical Center. She is a Past President of the American Academy of Addiction Psychiatry (AAAP), a Fellow of the American Society of Addiction Medicine (ASAM), and a Distinguished Fellow of both the American Psychiatric Association (APA) and AAAP.
Kenneth Morford, MD, FASAM is an Associate Professor and clinician educator at Yale School of Medicine. He trained as a general internist in the Yale Internal Medicine Primary Care Residency Program, served as a chief resident, and completed addiction medicine fellowship at Yale. He directs two HRSA-funded interprofessional addiction training programs, called CHAMP and SUSTAIN. He is the medical director of the Yale Physician Associate Program and serves as an associate program director for the Yale Addiction Medicine Fellowship Program. He provides primary care and addiction treatment at a community-based opioid treatment program and cares for patients on the addiction medicine consult service at Yale New Haven Hospital.